Biological Parameters for Evaluating the Toxic Potency of Petroleum Ether Extract of Wattakaka volubilis in Wistar Female Rats
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objectives: The present study investigated the toxic properties of petroleum ether extract of Wattakaka (W.) volubilis in Wistar female rats. Methods: An in vitro brine shrimp lethality bioassay was studied in A. Salina nauplii, and the lethality concentrations were assessed for petroleum ether extract of W. volubilis. A water soluble portion of the test extract was used in different concentrations from 100-1000 μg/mL of 1 mg/mL stock solution. A 24-hours incubation with a 1-mL aliquot in 50 mL of aerated sea water was considered to calculate the percentage rate of dead nauplii with test extract administration against a potassium-dichromate positive control. The acute and the sub-acute toxicities of petroleum ether extract of W. volubilis were evaluated orally by using gavage in female Wistar rats. Food and water intake, body weight, general behavioral changes and mortality of animals were noted. Toxicity or death was evaluated following the administration of petroleum ether extract for 28 consecutive days in the female rats. Serum biochemical parameters, such as alanine aminotransferase (ALT), alkaline phosphatase (ALP), bilirubin, total cholesterol, triglyceride, total protein, glucose, urea, creatinine, sodium, potassium and α-amylase levels, were measured in the toxicity evaluations. Pathological changes in isolated organs, such as the liver, kidneys, and pancreas, were also examined using hematoxylin and eosin dye fixation after the end of the test extract’s administration. Results: The results of the brine-shrimp assay indicate that the evaluated concentrations of petroleum ether extract of W. volubilis were found to be non-toxic. In the acute and the sub-acute toxicity evaluations, no significant differences were observed between the control animals and the animals treated with extract of W. volubilis. No abnormal histological changes were observed in any of the animal groups treated with petroleum ether extract of W. volubilis. Conclusion: These results suggest that petroleum ether extract of W. volubilis has a non-toxic effect in Wistar female rats.
Abstract
Objectives: The present study investigated the toxic properties of petroleum ether extract of Wattakaka (W.) volubilis in Wistar female rats. Methods: An in vitro brine shrimp lethality bioassay was studied in A. Salina nauplii, and the lethality concentrations were assessed for petroleum ether extract of W. volubilis. A water soluble portion of the test extract was used in different concentrations from 100-1000 μg/mL of 1 mg/mL stock solution. A 24-hours incubation with a 1-mL aliquot in 50 mL of aerated sea water was considered to calculate the percentage rate of dead nauplii with test extract administration against a potassium-dichromate positive control. The acute and the sub-acute toxicities of petroleum ether extract of W. volubilis were evaluated orally by using gavage in female Wistar rats. Food and water intake, body weight, general behavioral changes and mortality of animals were noted. Toxicity or death was evaluated following the administration of petroleum ether extract for 28 consecutive days in the female rats. Serum biochemical parameters, such as alanine aminotransferase (ALT), alkaline phosphatase (ALP), bilirubin, total cholesterol, triglyceride, total protein, glucose, urea, creatinine, sodium, potassium and α-amylase levels, were measured in the toxicity evaluations. Pathological changes in isolated organs, such as the liver, kidneys, and pancreas, were also examined using hematoxylin and eosin dye fixation after the end of the test extract’s administration. Results: The results of the brine-shrimp assay indicate that the evaluated concentrations of petroleum ether extract of W. volubilis were found to be non-toxic. In the acute and the sub-acute toxicity evaluations, no significant differences were observed between the control animals and the animals treated with extract of W. volubilis. No abnormal histological changes were observed in any of the animal groups treated with petroleum ether extract of W. volubilis. Conclusion: These results suggest that petroleum ether extract of W. volubilis has a non-toxic effect in Wistar female rats.
참고문헌 (28)
- Da Costa. JM., "Biological screening of araripe basin medicinal plants using artemia salina leach and pathogenic bacteria", Pharmacogn Mag, 6(24), pp.331~334 (2010)
- Panda N., "Pregnane glycosides", Nat Prod Comm, 3, pp.665~669 (2006)
- Kirtikar KR., "India medicinal plants, Bishen Singh Mahendrapal Singh", Dehradun, 3, pp.1635~ (2003)
- Ayyanar M., "Traditional herbal medicines used for the treatment of diabetes among two major tribal groups in south Tamil Nadu, India", Ethno Botanical Leaflet, 12, pp.276~280 (2008)
- Yoshimura S., "Studies on the constituents of asclepiadaceae plants. LVI. isolation of new antitumor-active glycosides from dregea volubilis(L. )BENTH", Chem Pharm Bull, 31(11), pp.3971~3983 (1983)
- Biswas M., "Antitumor effect of dregea volubilis fruit in ehrlich ascites carcinoma bearing mice", Global J Pharmacol, 4, pp.102~106 (2010)
- Biswas M., "A pentacyclic triterpenoid possessing analgesic activity from the fruits of dregea volubilis", Pharmacogn Mag, 5, pp.90~92 (2009)
- Arun kumar, R., "TMM Anti-hyperlipidemic and hypoglycemic activity of wattakaka volubilis methanol extract in alloxan-induced diabetic rats", J Pharma Res, 3, pp.1913~1915 (2010)
- Velmani G., "A critical biochemical assessment on the antihyperglycemic activity of aqueous fraction of wattakaka volubilis supported by antioxidant defense", Orient Pharm Exp Med, 14(1), pp.15~24 (2014)
- Hossain E., "Anti-inflammatory effect of a methanolic extract of leaves of dregea volubilis", J Ethnopharmacol, 132(2), pp.525~528 (2010)
- Nandi D., "Anti-leukemic activityof wattakaka volubilis leaf extract against human myeloid leukemia cell lines", J Ethnopharmacol, 144(2), pp.466~473 (2012)
- Hossain E., "Anthelmintic effect of a methanol extract of leaves of dregea volubilis on paramphistomum explanatum", Parasitol Res, 110(2), pp.809~814 (2012)
- Meyer B., "Brine shrimp : a convenient general bioassay for active plant constituents", Planta Medica, 45(5), pp.31~34 (1982)
- Solis PN., "A microwell cytotoxicity assay using artemia salina", Planta Medica, 59(3), pp.250~252 (1993)
- Cepleanu F., "Screening of tropical medicinal plants for molluscicidal, larvicidal, fungicidal and cytotoxic activities and brine shrimp toxicity", Pharm Biol, 32(3), pp.294~307 (1994)
- R. B. Suresh Kumar, "Pre clinical studies of Streblus asper Lour in terms of behavioural safety and toxicity", Oriental Pharmacy and Experimental Medicine, 11(4), pp.243~249 (2011), 한의학연구소
- OECD guide lines for the testing of chemicals, "section 4: health effects test no 423: Acute oral toxicity–Acute toxic class method", OECD, 2002
- OECD, "Guide-line for testing of chemicals. Guideline 407: Repeated Dose 28-day Oral Toxicity Study in Rodents", ~ (1995)
- Malek. D., "Repeated dose toxicity study (28 days) in rats and mice with N methylpyrrolidone (NMP)", Drug Chem Toxicol, 20(1-2), pp.63~77 (1997)
- Gupta M., "E Screening of panamanian medicinal plants for brine shrimp toxicity, crown gall tumor inhibition, cytotoxicity and DNA intercalation", Pharm Biol, 34(1), pp.19~27 (1996)
- Deciga-Campos M., "Acute toxicity and mutagenic activity of mexican plants used in traditional medicine", J Ethnopharmacol, 110(2), pp.334~342 (2007)
- Arts JH., "Subacute(28-day)toxicity of furfural in fischer 344 rats : a comparison of the oral and inhalation route", Food Chem Toxicol, 42(9), pp.1389~1399 (2004)
- Bautista ARPL., "Subacute toxicity assessment of annatto in rat", Food Chem Toxicol, 42(4), pp.625~629 (2004)
- Wannang NN., "Effect of cucumis metuliferus(cucurbitaceae)fruits on enzymes and haematological parameters in albino rats", Afr J Biotechnol, 6(22), pp.2515~2518 (2007)
- Mauer SM., "The kidney in diabetes", Am J Med, 70(3), pp.603~612 (1981)
- Almadal TP., "Strict insulin treatment normalizes the organic nitrogen contents and the capacity of urea–N synthesis in experimental diabetes in rats", Diabetologica, 31(2), pp.114~118 (1988)
- Kerl ME., "Diabetic ketoacidosis : pathophysiology and clinical laboratory presentation", Comp Cont Educ Pract Vet, 23(3), pp.220~229 (2001)
- Tarling CA., "The search for novel human pancreatic alpha-amylase inhibitors : high-throughput screening of terrestrial and marine natural product extracts", Chem Bio Chem, 9(3), pp.433~438 (2008)